Modified herpes simplex virus delivery of enhanced GFP into the central nervous system

J Neurosci Methods. 2002 Dec 15;121(2):211-9. doi: 10.1016/s0165-0270(02)00262-5.

Abstract

Controlled expression of proteins is a key experimental approach to a deeper understanding of the molecular basis of neuronal function. Here we evaluate the HSV-1 (herpes simplex virus) amplicon vector for gene delivery into the brains of living rats. We demonstrate that HSV-1 amplicon vectors expressing enhanced green fluorescent protein (EGFP) can reliably infect neurons after it is injected into cortex, striatum and thalamus in rats, producing sufficient numbers of infected neurons for electrophysiological experiments in acute brain slices. Expression of EGFP delivered by the HSV-1 amplicon was detected for up to 5 weeks post-infection. We detected no changes in the morphology or the electrophysiological properties of thalamic, striatal or cortical neurons within a period of at least 2 weeks after HSV-1 amplicon injection. We conclude that the HSV-1 amplicon is a valuable tool for gene delivery in the rat central nervous system.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cells, Cultured
  • Central Nervous System / cytology
  • Central Nervous System / metabolism*
  • Central Nervous System / virology
  • Gene Amplification
  • Gene Transfer Techniques*
  • Genetic Vectors*
  • Green Fluorescent Proteins
  • Herpesvirus 1, Human / genetics*
  • Immunohistochemistry
  • In Vitro Techniques
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Membrane Potentials / physiology
  • Patch-Clamp Techniques / methods
  • Rats
  • Rats, Sprague-Dawley
  • Transduction, Genetic

Substances

  • Luminescent Proteins
  • Green Fluorescent Proteins